Medical stocks in the medical sector need to consult relevant information before they can be untied. If you untie medical stocks in the medical sector according to years of study experience, you can get twice the result with half the effort. Here, I would like to share the relevant methods and experiences of medical units in the medical sector for your reference.

Medical units in the medical department

There are many pharmaceutical stocks in the medical sector. Here are some common ones:

_ _ Pharmaceutical business: Shanghai Pharmaceutical (60 1607), China Pharmaceutical (600560), Guangzhou Pharmaceutical (600332) and China Resources Pharmaceutical (03908).

_ _ Medical devices: Yuyue Medical (002223), Lepu Medical (300003), Wei Lan Medical (30 1060), Wanbangde (002006).

_ _ Biological products: Hualan Bio (002007), watson biological (300 142), Changchun Gaoxin (0066 1), zhifei Bio (300 122), Kangtai Bio (30060 1.

_ _ Pharmaceutical Manufacturing: Pien Tze Huang (600436), Yunnan Baiyao (000538)

_ _ Chemical Pharmaceuticals: Tiger Medicine (300378), Gloria Ying (00282 1), Zhao Yanxin Medicine (603 127), Shi Yao Science and Technology (300725), Kangmei Bio (300439).

_ _ Medical services: Aier Ophthalmology (3000 15), Tongce Medical (600655), Meinian Health (002044), Kangtai Bio (30060 1).

These companies are listed companies related to medicine in the medical sector of China A-share market. It should be noted that investment is risky, and investors should choose investment according to their own risk tolerance.

List of leading stocks in medical sector

The leading stocks in the medical sector are:

1. Mindray Medical: the leading stock. Domestic medical equipment leader, medical imaging, in vitro diagnosis, medical diagnosis and treatment in three major fields.

2.Opcon: the leader of ophthalmology.

3. The leader of 3.CRO clinical trial industry.

4. Huada Gene: the leader of gene sequencing.

5. Kangtai Bio: the leading vaccine.

6. zhifei Biology: The Leading Vaccine.

7. Hualan Bio: a leader in vaccines and blood products.

8. Innovative medicine leader.

9. Leading pharmaceutical companies.

10. My military creature: desensitizer faucet.

1 1. Hesko: innovative drug leader.

12. Qianzhen grass health: the leader of Chinese medicine.

13. Baiyun Mountain: a leading pharmaceutical enterprise.

14. New Cape: the leader of smart medical care.

15. Lop Medical: a leading instrument for cardiovascular diagnosis and treatment.

16. Leading medical devices.

17. Paulette: the leader of medical device health management.

18. Fan Jian Bio: the faucet of blood purification equipment.

19. Kangtai Bio: the second new share in the vaccine industry.

20. Hualan vaccine: a potential stock in the domestic vaccine industry.

The above list is for reference only. If you want to know more about the leading stocks in the medical sector, I suggest you consult more comprehensive official information or consult professionals.

What Chinese medicine stocks are there in the medical sector?

Chinese medicine stocks in the medical sector are:

1. Ling Rui Pharmaceutical: It has strong brand influence and competitiveness in the traditional Chinese medicine industry.

2. Jianmin Group: Focus on the big health field.

3. Taiji Group: abundant product reserves and diversified product lines. Its main products are Huoxiang Zhengqi Capsule, Jizhi Syrup, Compound Danshen Tablets and Banlangen Granules.

4. Huasen Pharmaceutical: The company has the independent production capacity of traditional Chinese medicine formula granules and chemical preparations.

Jiang Zhong Pharmaceutical Co., Ltd. is a traditional Chinese medicine pharmaceutical enterprise with a history of nearly 50 years.

6. Huluwa: The main products are pediatric drugs, gynecological drugs, antibiotics, anti-tumor drugs and so on.

7. Jianlong Co., Ltd.: Invest in the construction of Jianlong Yueqing Traditional Chinese Medicine Hospital (Longhui Traditional Chinese Medicine Hospital) to realize all-round cooperation in medical equipment, medical technology and drug supply and marketing.

8. Guizhou Lisan: It belongs to a large pharmaceutical enterprise engaged in research and development, production and sales of modern Chinese medicine.

9. Medicine Stone Technology: Its main business includes research and development, design and sales of drug molecular building blocks.

10. Division: Taigong Group Co., Ltd., the controlling shareholder of the company, holds 30% equity of Shandong Xinhua Pharmaceutical Group Co., Ltd.

1 1. Jianyou shares: it owns high-value drugs such as heparin sodium enteric-coated capsules, enoxaparin sodium injection, low-molecular-weight heparin calcium injection, nadroparin calcium injection and fondaparinux sodium injection.

12. Ganyuan: a pharmaceutical holding group specializing in the fields of pharmacy and pharmaceutical circulation.

13. Sinochem Yancheng: Committed to the research and development, production and sales of new nonmetallic mineral materials, relying on the original advantages and covering the engineering service field.

14. Fosun Pharma: The core business of Shanghai Fosun Pharma Co., Ltd. includes pharmacy, medical devices, medical diagnosis and medical and health services.

15. Jiuzhitang: Mainly engaged in the research, development, production and sales of products such as Lvjiao Buxue Granules, Liuwei Dihuang Pills and Suppositories.

16. Dong 'e Ejiao: The company is mainly engaged in research and development, production and sales of Ejiao series products.

17. Qianjin Pharmaceutical: The company is a large-scale comprehensive pharmaceutical enterprise integrating R&D and western medicine production and sales.

18. Hua En pharmaceutical co., ltd: leading products include central nervous system drugs and cardiovascular drugs, among which narcotic drugs account for half of the domestic market.

19. China resources Sanjiu: the leading otc drug in China, and its products include OTC, prescription drugs and anesthetics.

20. Laimei Pharmaceutical: The company is mainly engaged in pharmaceutical research and development, production and sales, and has a complete pharmaceutical industry chain.

2 1. Qianjin Pharmaceutical: The company is a large-scale comprehensive pharmaceutical enterprise integrating R&D and western medicine production and sales.

22. Jiuzhitang: It has independent production capacity of traditional Chinese medicine formula granules and chemical pharmaceutical preparations. The core products of Lvjiao Buxue Granule and Liuwei Dihuang Pill account for more than half of the company's revenue.

23. Dong 'e Ejiao: The company is mainly engaged in research and development, production and sales of Ejiao series products.

24. Angel Pharmaceutical: Its main business is research and development, production and sales of proprietary Chinese medicines.

25. Jiang Zhong Pharmaceutical Co., Ltd. is a Chinese medicine pharmaceutical enterprise with a history of nearly 50 years. We have a large number of classic Chinese patent medicines, such as Jiang Zhong Jianwei Xiaoshi tablets, Jiang Zhong Caoshanhu buccal tablets and Jiang Zhong Honeysuckle Granules.

26. Ling Rui Pharmaceutical Industry: It has strong brand influence and competitiveness in the traditional Chinese medicine industry. Its main products include Shufu Ointment, Zhuanggu Musk Ointment and so on.

27. Hua En Pharmaceutical: The leading products include central nervous system drugs and cardiovascular drugs, among which narcotic drugs account for half of the domestic market.

28. China Resources Shuanghe: The national first-class new drug "Tails", which focuses on the treatment of cardiovascular and cerebrovascular diseases, has reached the international leading level.

29. Teyi Pharmaceutical Co., Ltd.: Focus on the production and sales of cough-relieving and expectorant drugs. The main products are Zhikebao tablets, Phenomena Meimin tablets and Jinlian Qingre effervescent tablets.

30. Great Wall Pharmaceutical: The business scope is drug research and development, production and sales, and no specific products are listed at present.

Late stock selection of pharmaceutical sector

The late stock selection of the medical sector includes but is not limited to the following categories:

_ _ Companies that benefit from the real demand for medical services. Such companies usually have a long medical service chain and can provide high-quality medical services.

_ _ Innovative pharmaceutical industry chain related companies.

_ _ Companies whose policies involve medical informatization at the bottom.

_ _ Company with medical approval certificate.

_ _ A company with unique medical technology.

_ _ Hospitals in regional central cities.

The above contents are for reference only, investment is risky, and decision-making needs to be cautious.

Medical departments and military industrial units

The medical sector and military stocks are both important sectors in China stock market. The following are some comparisons between the medical sector and the military sector:

Medical sector:

_ _ medical plate is a collection of stocks in pharmaceutical manufacturing, biomedicine, medical devices and other industries.

_ _ The medical sector is usually considered as a relatively stable investment sector, because the medical industry is a long-term development industry and supported by government policies.

_ _ The share price of the medical sector is usually affected by macroeconomic, policy, epidemic situation and other factors.

Military stocks:

_ _ military stocks refer to the collection of stocks related to national defense and military industry.

_ _ Military stocks are usually considered as a relatively stable, high dividend and low-risk sector, because the military industry is a long-term and stable growth industry, and the performance of military enterprises is less affected by macroeconomics and policies.

_ _ The share price of military stocks is usually influenced by macroeconomic, international situation, policies and other factors.

Generally speaking, the medical sector and military stocks are relatively stable investment sectors, but the industry characteristics and influencing factors are different. Investors can choose the corresponding sectors and stocks according to their risk preferences and investment objectives.

The introduction of pharmaceutical stocks into the pharmaceutical sector is over.